Previous section Next section
COAGULATION
Body_ID: HC006019
Blood coagulation factors interact to form the secondary, fibrin-rich, hemostatic plug in small vessels, and the secondary fibrin thrombus in arteries and veins
Body_ID: P006026
Plasma coagulation factors are identified by roman numerals: they are listed in Table 6.2, together with some of their properties. Tissue factor was formerly known as factor III, calcium ion as factor IV; factor VI does not exist. Congenital deficiencies of other coagulation factors (I-XIII) result in excessive bleeding, which illustrates their physiologic importance in hemostasis. The exception is factor XII deficiency, which does not increase the bleeding tendency, despite prolonging blood clotting times in vitro; the same is true for its cofactors, prekallikrein or high-molecular-weight kininogen (HMWK). A possible explanation for this is given below.
Body_ID: P006027
Figure 6.4 illustrates the currently accepted scheme of blood coagulation. Since the early 1960s, this has been accepted as a 'waterfall' or 'cascade' sequence of interactive pro-enzyme to enzyme conversions, each enzyme activating the next pro-enzyme in the sequence(s). Activated factor enzymes are designated by the letter 'a' - for example, factor XIa. Traditionally, the scheme has been divided into three parts:
  • the intrinsic pathway,
  • the extrinsic pathway,
  • the final common pathway.
Body_ID: P006028
Body_ID: T006002
Table 6-2. Coagulation factors and some of their properties.
Body_ID: None
Coagulation factors and their properties
Body_ID: T006002.50
FactorSynonymsMolecular weight (Da)Plasma concentration (mg/dL)
Body_ID: T006002.100
IFibrinogen340000200-400
Body_ID: T006002.150
IIProthrombin7000010
Body_ID: T006002.200
IIITissue factor (thromboplastin)440000
Body_ID: T006002.250
IV*Calcium ion409-10
Body_ID: T006002.300
VProaccelerin, labile factor3300001
Body_ID: T006002.350
VIISerum prothrombin conversion accelerator (SPCA), stable factor480000.05
Body_ID: T006002.400
VIIIAntihemophilic factor (AHF)3300000.01
Body_ID: T006002.450
(vWF) (250000)n1
Body_ID: T006002.500
IXChristmas factor550000.3
Body_ID: T006002.550
XStuart-Prower factor590001
Body_ID: T006002.600
XIPlasma thromboplastin1600000.5
Body_ID: T006002.650
 antecedent (PTA)  
Body_ID: T006002.700
XIIHageman factor800003
Body_ID: T006002.750
XIIIFibrin-stabilizing factor (FSF)3200001-2
Body_ID: T006002.800
PrekallikreinFletcher factor850005
Body_ID: T006002.850
High-molecular-weight kininogen (HMWK)Fitzgerald, Flaujeac; or Williams factor, contact activation cofactor1200006
Body_ID: T006002.900
Body_ID: T006002.950
Body_ID: T006002

*To convert calcium ion to mmol/L multiply by 0.2495
n indicates number of subunits.
Body_ID: None
page 69
0
page 70
Body_ID: P0070
Body_ID: P006029
Body_ID: F006004
Figure 6.4 Blood coagulation: activation of coagulation factors. After the initiation of blood coagulation, the coagulation factor pro-enzymes are activated sequentially: activated factor enzymes are designated by the letter 'a'. The purple box indicates contact factors that have no apparent function in in vivo hemostasis. Phospholipids are supplied in vivo by platelets. HMWK, high-molecular-weight kininogen.
page 70
0
page 71
Body_ID: P0071
These are described below. They are distinguished on the basis of the nature of the initiating factor and its corresponding test in the clinical hemostasis laboratory; hence, three tests of coagulation are performed in clinical laboratories on citrated, platelet-poor plasma:
  • activated partial thromboplastin time (APTT),
  • prothrombin time,
  • thrombinView drug information time.
Body_ID: P006030
Platelet-poor plasma is used in these tests because the platelet count influences clotting time results. To obtain the platelet-poor plasma, citrate anticoagulant is added to blood to sequester calcium ions reversibly, and the blood is centrifuged at 2000 g for 15 minutes. The coagulation time tests are initiated by adding calcium and appropriate initiating agents.
Body_ID: P006031
Previous section
Bar end Bar end
Next section
Copyright © 2007 Elsevier Inc. All rights reserved. Read our Terms and Conditions of Use and our Privacy Policy.
For problems or suggestions concerning this service, please contact: studentconsult.help@elsevier.com